Pro: should asymptomatic patients with moderate-to-severe OSA be treated?

Substantial evidence points to a benefit with CPAP on cardiovascular and metabolic outcomes in asymptomatic patients with moderate-to-severe obstructive sleep apnoea http://ow.ly/FUxN30nkTqU

Detalles Bibliográficos
Autor principal: Ryan, Silke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395978/
https://www.ncbi.nlm.nih.gov/pubmed/30838054
http://dx.doi.org/10.1183/20734735.0340-2018
_version_ 1783399178792075264
author Ryan, Silke
author_facet Ryan, Silke
author_sort Ryan, Silke
collection PubMed
description Substantial evidence points to a benefit with CPAP on cardiovascular and metabolic outcomes in asymptomatic patients with moderate-to-severe obstructive sleep apnoea http://ow.ly/FUxN30nkTqU
format Online
Article
Text
id pubmed-6395978
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-63959782019-03-05 Pro: should asymptomatic patients with moderate-to-severe OSA be treated? Ryan, Silke Breathe (Sheff) Editorials Substantial evidence points to a benefit with CPAP on cardiovascular and metabolic outcomes in asymptomatic patients with moderate-to-severe obstructive sleep apnoea http://ow.ly/FUxN30nkTqU European Respiratory Society 2019-03 /pmc/articles/PMC6395978/ /pubmed/30838054 http://dx.doi.org/10.1183/20734735.0340-2018 Text en Copyright ©ERS 2019 http://creativecommons.org/licenses/by-nc/4.0/ Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0 (http://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Editorials
Ryan, Silke
Pro: should asymptomatic patients with moderate-to-severe OSA be treated?
title Pro: should asymptomatic patients with moderate-to-severe OSA be treated?
title_full Pro: should asymptomatic patients with moderate-to-severe OSA be treated?
title_fullStr Pro: should asymptomatic patients with moderate-to-severe OSA be treated?
title_full_unstemmed Pro: should asymptomatic patients with moderate-to-severe OSA be treated?
title_short Pro: should asymptomatic patients with moderate-to-severe OSA be treated?
title_sort pro: should asymptomatic patients with moderate-to-severe osa be treated?
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395978/
https://www.ncbi.nlm.nih.gov/pubmed/30838054
http://dx.doi.org/10.1183/20734735.0340-2018
work_keys_str_mv AT ryansilke proshouldasymptomaticpatientswithmoderatetosevereosabetreated

Ejemplares similares